Connect with us


The Biomechanics Institute Grows 20% in 2023, up to 12.4 Million Euros in Sales

The Biomechanics Institute (IBV) achieved 12.4 million euros in 2023, a 20% increase from the previous year, with 334 projects and 1,100 technological solutions developed for over 700 companies globally. International collaborations rose by 32%. Key projects included 3D anthropometry, digital health, and a prostate cancer screening device, generating 13.4 euros of social impact per euro invested.



biomechanics institute

The Biomechanics Institute (IBV) grows by double digits. The company has obtained revenues of 12.4 million euros during 2023, which represents an increase of 20% compared to the same period of the previous year. In 2023, the IBV has carried out 334 projects and has developed around 1,100 innovative technological solutions , working with more than 700 companies, both in Spain and in the rest of the world.

At the international level, there has been a 32% increase in companies that trust the Spanish center to evolve their lines of research, development and innovation (R&D&I) and acquire their technologies.

In this sense, during 2023 the Biomechanics Institute’s ‘s key projects have covered areas such as 3D anthropometry, digital health, biomedical engineering, human factors and user experience . In the field of health, in 2023, the IBV, through RI Medical, a joint venture company with the investment vehicle Redit Ventures, has developed a medical device aimed at screening for prostate cancer, the cancer with the highest rate of diagnosis. in Spain and Europe among the male gender and in second position worldwide.

The Biomechanics Institute has generated 13.4 euros of significant social impact for every euro invested

Aging, fragility and dependency have been the objective of the Impuls project (Innovations for active and healthy aging in the Valencian Community). And in relation to mobility, the Biomechanics Institute has developed software to humanize the future of the autonomous car .

In the field of child well-being, the Biomechanics Institute (IBV) has coordinated the European-funded project “Anthropometric Data for Children”, a study to measure the anthropometric and strength data of boys and girls in Europe .

In addition to these projects, another of the Biomechanics Institute notable lines covers the area of ​​occupational well-being, improving the productivity and ergonomics of work equipment (machinery, exoskeletons, protective equipment), including design and purchasing recommendations to incorporate the perspective of gender in clothing, footwear and other work items.

“We have consolidated the companies’ commitment and, in addition, we have generated a significant social impact by generating 13.4 euros for every euro invested ,” explained Javier Sánchez, managing director of the Biomechanics Institute.


(Featured image by via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us

Eva Wesley is an experienced journalist, market trader, and financial executive. Driven by excellence and a passion to connect with people, she takes pride in writing think pieces that help people decide what to do with their investments. A blockchain enthusiast, she also engages in cryptocurrency trading. Her latest travels have also opened her eyes to other exciting markets, such as aerospace, cannabis, healthcare, and telcos.